Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004
Serum and sputum interleukin-8: comparison between normal and allergic asthmatics children Source: Eur Respir J 2003; 22: Suppl. 45, 175s Year: 2003
Allergic inflammation in serum and sputum: comparison between healthy controls and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 393s Year: 2004
Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 217s Year: 2002
Sputum CC-chemokines, IL-13 and pulmonary function in allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004
Plasma eotaxin level in children with acute bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003
Relation of IgE, ECP and blood eosinophils to bronchial hyperreactivity in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 645s Year: 2007
IFNg, IL4 and TGFb in nasal lavage fluid of perennial allergic rhinitis patients and IL4 and TGFb in induced sputum of atopic asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 735s Year: 2005
Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002
IL-5 and GM-CSF positive cells in induced sputum from asthmatics and patients with non-allergic rhinitis with eosinophilia syndrome (NARES) Source: Eur Respir J 2001; 18: Suppl. 33, 529s Year: 2001
Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004
Iron in serum and induced sputum of patients with allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
Sputum eosinophilia vs exhaled NO as markers of airways inflammation in asthma: relationship with asthma control Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005
The relationship of serum interleukin-13 to asthma control in a sample of nigerian asthmatics. Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017
BAL eosinophil counts and specific clinical phenotypes of asthmatic and/or atopic children Source: Annual Congress 2011 - Flexible bronchoscopy in the diagnosis of paediatric lung diseases Year: 2011
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
eNO, ECP and bronchial hyperresponsiveness in mild asthmatic children out of therapy Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005
Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness Source: Annual Congress 2007 - Asthma subphenotypes Year: 2007
Cytokine plasma levels in moderate-to-severe asthmatic children with different asthma control Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020